BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29593358)

  • 1. Antitumor effect of antibiotic resistance gene-free plasmids encoding interleukin-12 in canine melanoma model.
    Lampreht Tratar U; Kos S; Kamensek U; Ota M; Tozon N; Sersa G; Cemazar M
    Cancer Gene Ther; 2018 Oct; 25(9-10):260-273. PubMed ID: 29593358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene Electrotransfer of Canine Interleukin 12 into Canine Melanoma Cell Lines.
    Lampreht U; Kamensek U; Stimac M; Sersa G; Tozon N; Bosnjak M; Brozic A; de Sá Oliveira GG; Nakagawa T; Saeki K; Cemazar M
    J Membr Biol; 2015 Oct; 248(5):909-17. PubMed ID: 25840833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tailor-made fibroblast-specific and antibiotic-free interleukin 12 plasmid for gene electrotransfer-mediated cancer immunotherapy.
    Kamensek U; Tesic N; Sersa G; Kos S; Cemazar M
    Plasmid; 2017 Jan; 89():9-15. PubMed ID: 27890562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene Electrotransfer of Plasmid-Encoding IL-12 Recruits the M1 Macrophages and Antigen-Presenting Cells Inducing the Eradication of Aggressive B16F10 Murine Melanoma.
    Lampreht Tratar U; Loiacono L; Cemazar M; Kamensek U; Fazio VM; Sersa G; Signori E
    Mediators Inflamm; 2017; 2017():5285890. PubMed ID: 28596641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maintenance and gene electrotransfer efficiency of antibiotic resistance gene-free plasmids encoding mouse, canine and human interleukin-12 orthologues.
    Kamensek U; Rencelj A; Jesenko T; Remic T; Sersa G; Cemazar M
    Heliyon; 2022 Feb; 8(2):e08879. PubMed ID: 35265755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor in situ vaccination effect of TNFα and IL-12 plasmid DNA electrotransfer in a murine melanoma model.
    Kamensek U; Cemazar M; Lampreht Tratar U; Ursic K; Sersa G
    Cancer Immunol Immunother; 2018 May; 67(5):785-795. PubMed ID: 29468364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced in-vitro and in-vivo suppression of A375 melanoma by combined IL-24/OSM adenoviral-mediated gene therapy.
    Xu Y; Zhang F; Qin L; Miao J; Sheng W; Xie Y; Xu X; Yang J; Qian H
    Melanoma Res; 2014 Feb; 24(1):20-31. PubMed ID: 24300090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene electrotransfer of IL-2 and IL-12 plasmids effectively eradicated murine B16.F10 melanoma.
    Komel T; Bosnjak M; Kranjc Brezar S; De Robertis M; Mastrodonato M; Scillitani G; Pesole G; Signori E; Sersa G; Cemazar M
    Bioelectrochemistry; 2021 Oct; 141():107843. PubMed ID: 34139572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved Specificity of Gene Electrotransfer to Skin Using pDNA Under the Control of Collagen Tissue-Specific Promoter.
    Kos S; Tesic N; Kamensek U; Blagus T; Cemazar M; Kranjc S; Lavrencak J; Sersa G
    J Membr Biol; 2015 Oct; 248(5):919-28. PubMed ID: 25840832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiosensitizing effect of intratumoral interleukin-12 gene electrotransfer in murine sarcoma.
    Sedlar A; Kranjc S; Dolinsek T; Cemazar M; Coer A; Sersa G
    BMC Cancer; 2013 Jan; 13():38. PubMed ID: 23360213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled gene delivery can enhance therapeutic outcome for cancer immune therapy for melanoma.
    Shirley SA; Lundberg CG; Li F; Burcus N; Heller R
    Curr Gene Ther; 2015; 15(1):32-43. PubMed ID: 25414028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratumoral delivery of interleukin 12 expression plasmids with in vivo electroporation is effective for colon and renal cancer.
    Tamura T; Nishi T; Goto T; Takeshima H; Dev SB; Ushio Y; Sakata T
    Hum Gene Ther; 2001 Jul; 12(10):1265-76. PubMed ID: 11440620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of p21 promoter for interleukin 12 radiation induced transcriptional targeting in a mouse tumor model.
    Kamensek U; Sersa G; Cemazar M
    Mol Cancer; 2013 Nov; 12(1):136. PubMed ID: 24219565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. pFARs, plasmids free of antibiotic resistance markers, display high-level transgene expression in muscle, skin and tumour cells.
    Marie C; Vandermeulen G; Quiviger M; Richard M; Préat V; Scherman D
    J Gene Med; 2010 Apr; 12(4):323-32. PubMed ID: 20209487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled Delivery of Plasmid DNA to Melanoma Tumors by Gene Electrotransfer.
    Heller R; Shi G
    Methods Mol Biol; 2021; 2265():635-644. PubMed ID: 33704744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy of anaplastic thyroid carcinoma with a single-chain interleukin-12 fusion protein.
    Shi Y; Parhar RS; Zou M; Baitei E; Kessie G; Farid NR; Alzahrani A; Al-Mohanna FA
    Hum Gene Ther; 2003 Dec; 14(18):1741-51. PubMed ID: 14670125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A combination of electrochemotherapy, gene electrotransfer of plasmid encoding canine IL-12 and cytoreductive surgery in the treatment of canine oral malignant melanoma.
    Milevoj N; Tratar UL; Nemec A; Brožič A; Žnidar K; Serša G; Čemažar M; Tozon N
    Res Vet Sci; 2019 Feb; 122():40-49. PubMed ID: 30453179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Administration route- and immune cell activation-dependent tumor eradication by IL12 electrotransfer.
    Li S; Zhang L; Torrero M; Cannon M; Barret R
    Mol Ther; 2005 Nov; 12(5):942-9. PubMed ID: 15953768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective tumor therapy with plasmid-encoded cytokines combined with in vivo electroporation.
    Lohr F; Lo DY; Zaharoff DA; Hu K; Zhang X; Li Y; Zhao Y; Dewhirst MW; Yuan F; Li CY
    Cancer Res; 2001 Apr; 61(8):3281-4. PubMed ID: 11309280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind placebo-controlled study with interleukin-18 and interleukin-12-encoding plasmid DNA shows antitumor effect in metastatic melanoma in gray horses.
    Müller J; Feige K; Wunderlin P; Hödl A; Meli ML; Seltenhammer M; Grest P; Nicolson L; Schelling C; Heinzerling LM
    J Immunother; 2011 Jan; 34(1):58-64. PubMed ID: 21150713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.